Cocrystal Pharma (COCP) Enterprise Value Growth (5y) (2015 - 2026)
Cocrystal Pharma (COCP) Enterprise Value Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.01% |
| Sep 30, 2025 | 24.34% |
| Jun 30, 2025 | 24.18% |
| Mar 31, 2025 | -134.37% |
| Dec 31, 2024 | -151.24% |
| Sep 30, 2024 | -16.66% |
| Jun 30, 2024 | -183.44% |
| Mar 31, 2024 | -20.46% |
| Dec 31, 2023 | -56.97% |
| Sep 30, 2023 | -44.69% |
| Jun 30, 2023 | -36.45% |
| Mar 31, 2023 | 34.85% |
| Dec 31, 2022 | -116.89% |
| Sep 30, 2022 | 35.51% |
| Jun 30, 2022 | 46.59% |
| Mar 31, 2022 | -103.89% |
| Dec 31, 2021 | -74.42% |
| Sep 30, 2021 | -59.82% |
| Jun 30, 2021 | -67.93% |
| Mar 31, 2021 | -26.58% |